CH424782A - Verfahren zur Herstellung von Tetrahydroisochinolinderivaten - Google Patents

Verfahren zur Herstellung von Tetrahydroisochinolinderivaten

Info

Publication number
CH424782A
CH424782A CH987462A CH987462A CH424782A CH 424782 A CH424782 A CH 424782A CH 987462 A CH987462 A CH 987462A CH 987462 A CH987462 A CH 987462A CH 424782 A CH424782 A CH 424782A
Authority
CH
Switzerland
Prior art keywords
sep
acetates
preparation
formula
products
Prior art date
Application number
CH987462A
Other languages
German (de)
English (en)
Inventor
Zoltan Dipl Ing Chem Meszaros
Szentmiklosi Pet Dipl-Ing-Chem
Czibula Iren
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of CH424782A publication Critical patent/CH424782A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH987462A 1961-08-30 1962-08-17 Verfahren zur Herstellung von Tetrahydroisochinolinderivaten CH424782A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUCI000380 1961-08-30
HUCI000390 1962-04-10

Publications (1)

Publication Number Publication Date
CH424782A true CH424782A (de) 1966-11-30

Family

ID=26318367

Family Applications (3)

Application Number Title Priority Date Filing Date
CH987462A CH424782A (de) 1961-08-30 1962-08-17 Verfahren zur Herstellung von Tetrahydroisochinolinderivaten
CH781566A CH425793A (de) 1961-08-30 1962-08-17 Verfahren zur Herstellung von Tetrahydroisochinolin-derivaten
CH781466A CH424783A (de) 1961-08-30 1962-08-17 Verfahren zur Herstellung von Tetrahydroisochinolinderivaten

Family Applications After (2)

Application Number Title Priority Date Filing Date
CH781566A CH425793A (de) 1961-08-30 1962-08-17 Verfahren zur Herstellung von Tetrahydroisochinolin-derivaten
CH781466A CH424783A (de) 1961-08-30 1962-08-17 Verfahren zur Herstellung von Tetrahydroisochinolinderivaten

Country Status (5)

Country Link
CH (3) CH424782A (fi)
DK (1) DK104513C (fi)
FI (1) FI40718B (fi)
FR (1) FR2057M (fi)
GB (1) GB1011554A (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103664781B (zh) * 2013-12-13 2015-12-09 浙江普洛康裕制药有限公司 盐酸屈他维林晶型i和晶型ii及制备方法
CN103694171B (zh) * 2013-12-13 2016-06-29 浙江普洛康裕制药有限公司 盐酸屈他维林晶型iii和晶型iv及其制备方法

Also Published As

Publication number Publication date
FI40718B (fi) 1969-01-31
DK104513C (da) 1966-05-31
CH424783A (de) 1966-11-30
FR2057M (fr) 1963-10-07
CH425793A (de) 1966-12-15
GB1011554A (en) 1965-12-01

Similar Documents

Publication Publication Date Title
DE1670849C3 (de) Verfahren zur Herstellung von 8-Acylamino-1,23,4-tetrahydroisochinolinen
DE1939809C3 (fi)
DE2265169B2 (de) Vincaminsäureäthylester, Herstellungsverfahren und pharmazeutische Mittel
DE2308883C3 (de) 2-Phenylamino-thienylmethyl-imidazoline-(2), Verfahren zur Herstellung derselben und diese enthaltene Arzneimittel
AT234693B (de) Verfahren zur Herstellung von neuen Isochinolinderivaten
CH424782A (de) Verfahren zur Herstellung von Tetrahydroisochinolinderivaten
CH497422A (de) Verfahren zur Herstellung organischer Sulfoxyde
DE1250828B (de) Verfahren zur Herstellung des spasmolytisch wirksamen 6,7,3',4' - Tetraäthoxy -l-benzyliden-1,2,3,4tetrahydroisochinolins und seiner Salze
DE2166270C3 (de) Nicotinoylaminoäthansulfonyl-2amino-thiazol
DE2144077C3 (de) Neue Hydroxyäthylaminoalkylpiperazine und Verfahren zu deren Herstellung
DE2211214B2 (de) -Alkylester, Verfahren zu deren Herstellung sowie diese enthaltende pharmazeutische Zubereitungen
DE941193C (de) Verfahren zur Herstellung von neuen, bisquaternaeren Phosphoniumverbindungen
EP0148742B1 (de) 2-(2-Thienyl)-imidazo[4,5-b]pyridin-derivate und pharmazeutisch verträgliche Säureadditionssalze hiervon sowie Verfahren zu deren Herstellung
AT251585B (de) Verfahren zur Herstellung von neuen 6,7-Dihydro-5H-pyrrolo-[3,4-d]-pyrimidinen
CH533619A (de) Verfahren zur Herstellung von Pyrrolderivaten
AT354432B (de) Verfahren zur herstellung von 3-indolylessig- saeuren
DE3620215A1 (de) Benzamide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE896047C (de) Verfahren zur Herstellung von Salicylsaeurederivaten
DE2650999A1 (de) N-methylolamide, ihre herstellung und verwendung
AT205037B (de) Verfahren zur Herstellung eines neuen Thioxanthen-Derivates
DE1795506C3 (de) 14.08.59 Dänemark 2919-59 2-Chlor-9-eckige Klammer auf 3'-(N'-2hydroxyäthylplperazin-N) propyIiden eckige Klammer zu- thiaxanthen, Verfahren zu seiner Herstellung und diese enthaltende Arzneimittel
DE1090224B (de) Verfahren zur Herstellung von substituierten 3, 5-Dioxo-tetrahydro-1, 2, 6-thiadiazin-1, 1-dioxyden
DE1292660B (de) Verfahren zur Herstellung von p-(Bis-ª‰-chloraethyl-amino)-phenylalanin-hydrochlorid
AT273132B (de) Verfahren zur Herstellung von neuen Pyridyl-tetrahydroisochinolinen sowie von deren Säureaddtionssalzen
DE920546C (de) Verfahren zur Herstellung von Derivaten des 3-(4'-Oxyphenyl)-3-(4"-oxy-3"-aminomethyl-phenyl)-oxindols